Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
Ergebnis 3 von 456

Details

Autor(en) / Beteiligte
Titel
Utility of the chromogenic and fluorogenic properties of benzofurazan for the assay of milnacipran in human urine and plasma
Ist Teil von
  • RSC advances, 2018-01, Vol.8 (39), p.22154-22160
Ort / Verlag
England: Royal Society of Chemistry
Erscheinungsjahr
2018
Quelle
EZB Electronic Journals Library
Beschreibungen/Notizen
  • Our article presents the development and validation of two simple, very sensitive, and low-cost spectroscopic methods for the assay of milnacipran hydrochloride in bulk form, pharmaceutical tablets and spiked human urine and plasma. Spectroscopic methods (spectrophotometric and spectrofluorimetric techniques) were dependent on the chromogenic and fluorogenic properties of the 4-chloro-7 nitrobenzofurazan (NBD-Cl) reagent. The reaction product, resulting from the interaction between NBD-Cl and milnacipran in the presence of borate buffer pH 8.5, was measured spectrophotometrically at 465 nm and spectrofluorimetrically at 510 nm after excitation at 465 nm. The absorbance-concentration plot was rectilinear over the range of 1.5-12 μg mL with a limit of quantitation 1.09 μg mL , while the fluorescence-concentration plot was rectilinear over the range of 0.03-0.5 μg mL with a limit of quantitation 0.02 μg mL . Influential parameters affecting the development and stability of the reaction product were studied and optimized. Assurance of the cited drug in its tablets by our proposed methods was successfully completed without obstruction from the presence of the basic excipients with average percentage recoveries of 99.27 ± 1.18 and 99.44 ± 0.69 for the spectrophotometric and spectrofluorimetric methods, respectively. The spectrofluorimetric method was additionally adopted as a preliminary study for the assay of the cited drug in spiked human urine and plasma with average percentage recoveries of 101.52 ± 1.01 and 100.38 ± 1.57 for spiked urine and plasma, respectively.
Sprache
Englisch
Identifikatoren
ISSN: 2046-2069
eISSN: 2046-2069
DOI: 10.1039/c8ra03614d
Titel-ID: cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9081200

Weiterführende Literatur

Empfehlungen zum selben Thema automatisch vorgeschlagen von bX